Prentiss Smith & Co’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-99,708
Closed -$7.64M 77
2021
Q4
$7.64M Buy
99,708
+23,674
+31% +$2.09M 3.61% 5
2021
Q3
$7.31M Buy
76,034
+188
+0.2% +$20.5K 3.71% 4
2021
Q2
$8.09M Sell
75,846
-1,801
-2% -$177K 3.9% 4
2021
Q1
$6.96M Buy
77,647
+134
+0.2% +$14.7K 3.57% 6
2020
Q4
$7.79M Sell
77,513
-10,921
-12% -$814K 3.72% 8
2020
Q3
$4.32M Sell
88,434
-990
-1% -$47.5K 2.25% 22
2020
Q2
$3.65M Buy
+89,424
New +$2.57M 2.25% 21

Other funds holding CRNC

Prentiss Smith & Co's CRNC Position: Q1 2022 in Review

Prentiss Smith & Co sold out of Cerence (CRNC) in Q1 2022, closing a stake of 99,708 shares — an estimated $7.64M sold.

Prentiss Smith & Co first reported a position in CRNC in Q2 2020 and held it in 7 quarters. The position peaked at $8.09M in Q2 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • Prentiss Smith & Co reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • Prentiss Smith & Co sold 99,708 Cerence shares in Q1 2022, an estimated $7.64M.
  • Prentiss Smith & Co first reported a position in Cerence in Q2 2020 and held it in 7 quarters.
  • Prentiss Smith & Co's Cerence position peaked at $8.09M in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Prentiss Smith & Co's 13F filing for Q1 2022, filed 9 May 2022.